USA - NYSE:GENI - GG00BMF1JR16 - Common Stock
The current stock price of GENI is 11.93 USD. In the past month the price decreased by -6.72%. In the past year, price increased by 58.43%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
FLUT | FLUTTER ENTERTAINMENT PLC-DI | 31.84 | 44.19B | ||
LVS | LAS VEGAS SANDS CORP | 20.57 | 33.32B | ||
DKNG | DRAFTKINGS INC-CL A | N/A | 16.93B | ||
WYNN | WYNN RESORTS LTD | 21.5 | 12.25B | ||
MGM | MGM RESORTS INTERNATIONAL | 12.79 | 8.60B | ||
SRAD | SPORTRADAR GROUP AG-A | 52.7 | 7.88B | ||
BYD | BOYD GAMING CORP | 11.82 | 6.60B | ||
SGHC | SUPER GROUP SGHC LTD | 42.77 | 6.49B | ||
LNW | LIGHT & WONDER INC | 19.23 | 6.39B | ||
RRR | RED ROCK RESORTS INC-CLASS A | 23.28 | 6.19B | ||
CHDN | CHURCHILL DOWNS INC | 14.94 | 6.35B | ||
RSI | RUSH STREET INTERACTIVE INC | 54.06 | 3.95B |
Genius Sports Ltd. engages in the provision of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its products: Sports Technology and Services, Betting Technology, Content and Services and Media Technology, Content and Services. The company builds and supplies technology and services that allow sports leagues to collect, analyze and monetize their data with added tools to deepen fan engagement. The company provides sports leagues with bespoke monitoring technology and education services to help protect their competitions and athletes from the threats of match fixing and betting-related corruption. The company offers official data, outsourced bookmaking, trading/risk management services and live audio-visual game content that is derived from its streaming partnerships with sports leagues. The company builds and supplies technology, services and data that enables sportsbooks, sports organizations and other brands to target, acquire and retain sports fans as their customers.
GENIUS SPORTS LTD
27 Soho Square, 1St Floor, Genius Sports Group
London SW1Y 6DN GB
CEO: Mark Locke
Employees: 2400
Phone: 4402078514060
The current stock price of GENI is 11.93 USD. The price decreased by -0.17% in the last trading session.
The exchange symbol of GENIUS SPORTS LTD is GENI and it is listed on the New York Stock Exchange, Inc. exchange.
GENI stock is listed on the New York Stock Exchange, Inc. exchange.
25 analysts have analysed GENI and the average price target is 15.3 USD. This implies a price increase of 28.25% is expected in the next year compared to the current price of 11.93. Check the GENIUS SPORTS LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.
GENIUS SPORTS LTD (GENI) has a market capitalization of 3.02B USD. This makes GENI a Mid Cap stock.
GENIUS SPORTS LTD (GENI) currently has 2400 employees.
GENIUS SPORTS LTD (GENI) has a support level at 11.81 and a resistance level at 13.51. Check the full technical report for a detailed analysis of GENI support and resistance levels.
The Revenue of GENIUS SPORTS LTD (GENI) is expected to grow by 26% in the next year. Check the estimates tab for more information on the GENI EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
GENI does not pay a dividend.
GENIUS SPORTS LTD (GENI) will report earnings on 2025-11-10, before the market open.
GENIUS SPORTS LTD (GENI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.31).
The outstanding short interest for GENIUS SPORTS LTD (GENI) is 11.23% of its float. Check the ownership tab for more information on the GENI short interest.
ChartMill assigns a technical rating of 7 / 10 to GENI. When comparing the yearly performance of all stocks, GENI is one of the better performing stocks in the market, outperforming 88.11% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to GENI. While GENI has a great health rating, there are worries on its profitability.
Over the last trailing twelve months GENI reported a non-GAAP Earnings per Share(EPS) of -0.31. The EPS increased by 18.42% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -8.39% | ||
ROE | -10.81% | ||
Debt/Equity | 0 |
25 analysts have analysed GENI and the average price target is 15.3 USD. This implies a price increase of 28.25% is expected in the next year compared to the current price of 11.93.
For the next year, analysts expect an EPS growth of 30.31% and a revenue growth 26% for GENI